List of Excipients in API tafenoquine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tafenoquine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals INC | ARAKODA | tafenoquine | 71475-257 | CELLULOSE, MICROCRYSTALLINE | 2035-12-02 |
| 60 Degrees Pharmaceuticals INC | ARAKODA | tafenoquine | 71475-257 | FERRIC OXIDE RED | 2035-12-02 |
| 60 Degrees Pharmaceuticals INC | ARAKODA | tafenoquine | 71475-257 | HYPROMELLOSE | 2035-12-02 |
| 60 Degrees Pharmaceuticals INC | ARAKODA | tafenoquine | 71475-257 | MAGNESIUM STEARATE | 2035-12-02 |
| 60 Degrees Pharmaceuticals INC | ARAKODA | tafenoquine | 71475-257 | MANNITOL | 2035-12-02 |
| 60 Degrees Pharmaceuticals INC | ARAKODA | tafenoquine | 71475-257 | POLYETHYLENE GLYCOL | 2035-12-02 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for tafenoquine
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tafenoquine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
tafenoquine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
tafenoquine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tafenoquine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
tafenoquine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
tafenoquine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tafenoquine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| 60 Degrees Pharmaceuticals INC | tafenoquine | 71475-257 |
| GlaxoSmithKline LLC | tafenoquine succinate | 0173-0889 |
| >Company | >Ingredient | >NDC |
tafenoquine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
